Inventor
ABURATANI HIROYUKI
JP27 patents
⚠️ This page may combine multiple inventors who share the name “ABURATANI HIROYUKI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABURATANI HIROYUKI
13 patentsUS9017684B2Apr 28, 2015
Diagnosis and treatment of cancer using anti-EREG antibody
ABURATANI HIROYUKI10 citations84
US8263077B2Sep 11, 2012
Cell growth inhibitors containing anti-glypican 3 antibody
ABURATANI HIROYUKI11 citations84
US8455249B2Jun 4, 2013
Highly effective anti-cadherin antibody for induction of antibody-dependent cellular cytotoxicity in vivo
ABURATANI HIROYUKI6 citations80
US9274119B2Mar 1, 2016
Anti-CLDN6 antibody
ABURATANI HIROYUKI8 citations79
US9139647B2Sep 22, 2015
Diagnosis and treatment of cancer using anti-TM4SF20 antibody
ABURATANI HIROYUKI3 citations60
US7812128B2Oct 12, 2010
Gene overexpressed in cancer
ABURATANI HIROYUKI3 citations58
US8273859B2Sep 25, 2012
Diagnostic agent and therapeutic agent for pancreatic cancer
ABURATANI HIROYUKI0 citations50
US8211630B2Jul 3, 2012
Diagnostic agent and therapeutic agent for pancreatic cancer
ABURATANI HIROYUKI0 citations50
US9644029B2May 9, 2017
Cancer diagnosis and treatment of cancer using anti-ROBO1 antibody
ABURATANI HIROYUKI0 citations49
US9376475B2Jun 28, 2016
Gene overexpressed in cancer
ABURATANI HIROYUKI0 citations48
US9434775B2Sep 6, 2016
Gene overexpressed in cancer
ABURATANI HIROYUKI0 citations47
US9079957B2Jul 14, 2015
Diagnosis and treatment of cancer using anti-TMPRSS11E antibody
ABURATANI HIROYUKI0 citations39
US8940488B2Jan 27, 2015
Cancer diagnosis and treatment of cancer using anti-robo 1 antibody
ABURATANI HIROYUKI0 citations37
UNIV TOKYO
5 patentsUS7875705B2Jan 25, 2011
Tumor diagnostic agent used in PET comprising anti-ROBO1 antibody
UNIV TOKYO10 citations78
US9920129B2Mar 20, 2018
Diagnosis and treatment of cancer using anti-ITM2A antibody
UNIV TOKYO1 citations50
US7794982B2Sep 14, 2010
Method for identifying gene with varying expression levels
UNIV TOKYO0 citations50
US9017683B2Apr 28, 2015
Highly effective anti-cadherin antibody for induction of antibody-dependent cellular cytotoxicity in vivo
UNIV TOKYO0 citations48
US10563265B2Feb 18, 2020
Use of RHOA in cancer diagnosis and inhibitor screening
UNIV TOKYO0 citations46
CHUGAI PHARMACEUTICAL CO LTD
3 patentsUS11111311B2Sep 7, 2021
Anti-DLL3 antibody
CHUGAI PHARMACEUTICAL CO LTD9 citations85
US7744880B2Jun 29, 2010
Cell growth inhibitors containing anti-glypican 3 antibody
CHUGAI PHARMACEUTICAL CO LTD13 citations84
US10696743B2Jun 30, 2020
Diagnosis and treatment of cancer using anti-desmoglein-3 antibodies
CHUGAI PHARMACEUTICAL CO LTD0 citations51